Dr.Evidence® Appoints Ken Kobayashi, MD, FACP to its Medical Strategy Advisory Board

SANTA MONICA, Calif.--(BUSINESS WIRE)--Dr.Evidence is pleased to announce the appointment of Ken Kobayashi, MD, FACP to the MSAB. He joins Chair, Calum MacRae, MB, ChB, PhD, BSc, and members, Michael Klag, MD, MPH, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD. Dr. Kobayashi has a deep background as a clinician-scientist, regulator, scientific diplomat and drug developer across the US, Europe, Latin America, and Japan/Asia. As a senior executive in top-tier pharmaceutical companies includin